Matthew Balk, 10% Owner at AzurRx BioPharma, Inc. (AZRX), sold 160,000 shares at $3.00 ($510K) on 2017-06-30, disclosed to the SEC on 2017-07-05.
Open-market sale of $510k AZRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 100,000 | $300K | 58.8% |
| 2 | $3.50 | 60,000 | $210K | 41.2% |
| Total | $3.19 avg | 160,000 | $510K | 100% |